Jacobs Levy Equity Management, Inc Novo Cure LTD Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $4.45 Million - $6.19 Million	358,062 Added 305.61%	475,226 $7.43 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $1.06 Million - $1.5 Million	95,202 Added 433.49%	117,164 $1.75 Million
Q3 2023 Nov 16, 2023	BUY	$16.15 - $42.35 $354,686 - $930,090	21,962 New	21,962 $354,000
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $27.3 Million - $47.2 Million	-209,211 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $3.38 Million - $5.17 Million	27,209 Added 14.95%	209,211 $27.7 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $11.9 Million - $18.4 Million	105,892 Added 139.13%	182,002 $31.5 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $579,919 - $1.11 Million	-9,990 Reduced 11.6%	76,110 $8.47 Million
Q2 2020 Aug 17, 2020	BUY	$57.2 - $74.41 $2.13 Million - $2.77 Million	37,245 Added 76.24%	86,100 $5.11 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $59,046 - $99,101	-1,035 Reduced 2.07%	48,855 $3.29 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $2.49 Million - $3.42 Million	-36,443 Reduced 42.21%	49,890 $4.2 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $1.19 Million - $1.89 Million	-19,290 Reduced 18.26%	86,333 $6.46 Million
Q2 2019 Aug 13, 2019	BUY	$42.22 - $63.23 $8,021 - $12,013	190 Added 0.18%	105,623 $6.68 Million
Q1 2019 May 14, 2019	BUY	$31.96 - $56.12 $574,321 - $1.01 Million	17,970 Added 20.55%	105,433 $5.08 Million
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $125,334 - $229,677	4,364 Added 5.25%	87,463 $2.93 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $1.43 Million - $2.34 Million	44,569 Added 115.67%	83,099 $4.35 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $764,820 - $1.23 Million	38,530 New	38,530 $1.21 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$215 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$210 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$140 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$76.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$53.7 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account